- Home
- ITOS vs ABEO Comparison
ITOS vs ABEO Comparison
Compare ITOS & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITOS
- ABEO
- Stock Information
- Founded
- ITOS 2011
- ABEO 1974
- Country
- ITOS United States
- ABEO United States
- Employees
- ITOS N/A
- ABEO N/A
- Industry
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- ITOS Health Care
- ABEO Health Care
- Exchange
- ITOS Nasdaq
- ABEO Nasdaq
- Market Cap
- ITOS 270.7M
- ABEO 256.9M
- IPO Year
- ITOS 2020
- ABEO 1980
- Fundamental
- Price
- ITOS $9.99
- ABEO $5.93
- Analyst Decision
- ITOS Hold
- ABEO Strong Buy
- Analyst Count
- ITOS 6
- ABEO 6
- Target Price
- ITOS $10.60
- ABEO $18.00
- AVG Volume (30 Days)
- ITOS 1.8M
- ABEO 903.2K
- Earning Date
- ITOS 08-07-2025
- ABEO 08-11-2025
- Dividend Yield
- ITOS N/A
- ABEO N/A
- EPS Growth
- ITOS N/A
- ABEO N/A
- EPS
- ITOS N/A
- ABEO N/A
- Revenue
- ITOS $35,000,000.00
- ABEO N/A
- Revenue This Year
- ITOS N/A
- ABEO N/A
- Revenue Next Year
- ITOS N/A
- ABEO $323.51
- P/E Ratio
- ITOS N/A
- ABEO N/A
- Revenue Growth
- ITOS 177.89
- ABEO N/A
- 52 Week Low
- ITOS $4.80
- ABEO $3.93
- 52 Week High
- ITOS $18.13
- ABEO $7.32
- Technical
- Relative Strength Index (RSI)
- ITOS 65.96
- ABEO 45.53
- Support Level
- ITOS $9.93
- ABEO $6.10
- Resistance Level
- ITOS $10.21
- ABEO $6.24
- Average True Range (ATR)
- ITOS 0.18
- ABEO 0.29
- MACD
- ITOS -0.11
- ABEO -0.09
- Stochastic Oscillator
- ITOS 18.07
- ABEO 4.26
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.